Clinical Trials Browser

OTHER × Sarcoma × Vinorelbine × Clear all

Rhabdomyosarcoma, Sarcoma

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT02331251 2018-07-02

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Phase 1/2 Terminated

81 enrolled

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT00004105 2011-03-28

Combination Chemotherapy in Treating Patients With Advanced Cancer

Phase 1/2 Completed

LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fibrosarcoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Sarcoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00134641 2007-12-21

Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas

Phase 2 Completed

40 enrolled

Sarcoma

Clinical Trials

Evolutionary Therapy for Rhabdomyosarcoma

SMMART Adaptive Clinical Treatment (ACT) Trial

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Combination Chemotherapy in Treating Patients With Advanced Cancer

Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas